![Joerg Alte](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joerg Alte
Corporate Officer/Principal bij FIDEsprit AG
Actieve functies van Joerg Alte
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FIDEsprit AG | Corporate Officer/Principal | 01-09-2007 | - |
Loopbaan van Joerg Alte
Eerdere bekende functies van Joerg Alte
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SANGUI BIOTECH INTERNATIONAL, INC. | President | 01-11-1998 | 01-04-2000 |
PROTEO, INC. | Directeur/Bestuurslid | 01-01-2000 | - |
Statistieken
Internationaal
Verenigde Staten | 2 |
Duitsland | 2 |
Zwitserland | 2 |
Operationeel
Director/Board Member | 1 |
President | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SANGUI BIOTECH INTERNATIONAL, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Proteo, Inc.
![]() Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
FIDEsprit AG |
- Beurs
- Insiders
- Joerg Alte
- Ervaring